LB Pharmaceuticals Inc
LBRX
$29.66
-$1.75-5.57%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 23.85% | -6.13% | 2,110.75% | -49.19% | 0.00% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 39.20% | 28.10% | 245.68% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 86.03% | -- | -- | -- | -- |
| Total Current Assets | 26.15% | -2.52% | 2,040.59% | -- | -- |
|
|
|||||
| Total Current Assets | 26.15% | -2.52% | 2,040.59% | -- | -- |
| Net Property, Plant & Equipment | -2.68% | -2.64% | -3.18% | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.78% | 50.39% | 0.79% | -- | -- |
| Total Assets | 25.74% | -2.44% | 1,566.39% | -- | -- |
|
|
|||||
| Total Accounts Payable | 234.70% | -17.88% | 307.87% | -- | -- |
| Total Accrued Expenses | -33.33% | 37.81% | 30.93% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.00% | 0.00% | 0.00% | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 46.55% | 11.96% | 70.17% | -- | -- |
|
|
|||||
| Total Current Liabilities | 46.55% | 11.96% | 70.17% | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.49% | -3.30% | -3.13% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -14.89% | 42.57% | -51.06% | -- | -- |
| Total Liabilities | 27.23% | 10.44% | 18.77% | -- | -- |
|
|
|||||
| Common Stock & APIC | 22.38% | 0.55% | 3,930.58% | -- | -- |
| Retained Earnings | -14.71% | -9.72% | -3.11% | -- | -- |
| Treasury Stock & Other | 23.81% | 416.98% | -- | -- | -- |
| Total Common Equity | 25.68% | -2.87% | 398.65% | -9.86% | 0.00% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | 0.00% | 0.00% |
|
|
|||||
| Total Common Equity | 25.68% | -2.87% | 398.65% | -9.86% | 0.00% |
| Total Preferred Equity | -- | -- | -- | 0.00% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 25.68% | -2.87% | 2,886.92% | -47.29% | 0.00% |
|
|
|||||